Search Results for 'shai n. gozani'
-
NeuroMetrix Awarded New U.S. Patent for Automated Control of Quell Therapy During Sleep
The patent also includes claims related to providing device users with feedback about their sleep.Business Wire 08.30.17
-
NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan
The deal completes the product transition to Fukuda Denshi.Business Wire 08.15.17
-
NeuroMetrix Promotes From Within to Fill Executive Position
A 15-year employee is rewarded with role of senior vice president and general manager of diagnostics.Business Wire 07.21.17
-
NeuroMetrix Reports Substantial Expansion of International IP Assets for Quell Technology
The allowed patent claims address an essential element in the company’s proprietary technology.Business Wire 05.23.17
-
CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Chronic Pain Sufferers
Company unveils advanced product features for Quell Wearable Pain Relief Technology at show.Business Wire 01.05.17
-
NeuroMetrix Reports Final Approval to Market DPNCheck in China
Omron leading local initiatives.Business Wire 09.15.16
-
NeuroMetrix Revenue Skyrockets in Second Quarter
Year-over-year proceeds up 116 percent.Businesswire 07.22.16
-
Study to Assess the Impact of Quell Technology on Opioid Use and Pain in Cancer Patients
Study is 10-week single site, double blinded, sham controlled randomized clinical trial.Business Wire 06.27.16
-
NeuroMetrix Pain Relief Device Now Available in Chain Drug Stores
Device gives users the option to start, stop, and adjust therapy via their smartphone.Business Wire 06.03.16
